These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Education and imaging. Gastrointestinal: gastric Crohn's disease. Tseng TC; Chang YT; Wong JM J Gastroenterol Hepatol; 2007 Oct; 22(10):1690. PubMed ID: 17845696 [No Abstract] [Full Text] [Related]
23. Gastrointestinal sarcoidosis resembling Crohn's disease. Bulger K; O'Riordan M; Purdy S; O'Brien M; Lennon J Am J Gastroenterol; 1988 Dec; 83(12):1415-7. PubMed ID: 3195549 [TBL] [Abstract][Full Text] [Related]
24. Unusual association of Hodgkin's disease and sarcoidosis. Simsek S; van Leuven F; Bronsveld W; Ooms GH; Groeneveld AB; de Graaff CS Neth J Med; 2002 Dec; 60(11):438-40. PubMed ID: 12685492 [TBL] [Abstract][Full Text] [Related]
25. Inflammatory pseudotumor of the liver as the first manifestation of Crohn's disease. Amankonah TD; Strom CB; Vierling JM; Petrovic LM Am J Gastroenterol; 2001 Aug; 96(8):2520-2. PubMed ID: 11513216 [No Abstract] [Full Text] [Related]
26. Crohn's disease presenting as life-threatening ileal bleeding. Tysk C; De Keersmaecker J; Al-Been H; Ahmad TM Saudi Med J; 2000 Oct; 21(10):971-3. PubMed ID: 11369966 [TBL] [Abstract][Full Text] [Related]
27. Cauda equina and conus medullaris syndrome in sarcoidosis. Kaiboriboon K; Olsen TJ; Hayat GR Neurologist; 2005 May; 11(3):179-83. PubMed ID: 15860141 [TBL] [Abstract][Full Text] [Related]
28. [Recurrent aseptic osteonecrosis in Crohn's disease - extraintestinal manifestation or steroid related complication?]. Lanyi B; Dienes HP; Kruis W Dtsch Med Wochenschr; 2005 Aug; 130(34-35):1944-7. PubMed ID: 16123897 [TBL] [Abstract][Full Text] [Related]
31. [Are granulomas necessary for the final diagnosis of Crohn disease?]. Ferrer JD; Lavado G; Prado W; López R; Carballo F Rev Gastroenterol Peru; 2004; 24(2):171-4. PubMed ID: 15241496 [TBL] [Abstract][Full Text] [Related]
32. Crohn's disease and secondary amyloidosis: early complication? A case report and review of the literature. Basturk T; Ozagari A; Ozturk T; Kusaslan R; Unsal A J Ren Care; 2009 Sep; 35(3):147-50. PubMed ID: 19689697 [TBL] [Abstract][Full Text] [Related]
33. The suspension of an announced trial on relapse prevention in Crohn's ileitis with a 5-ASA formulation in microgranular form. Prantera C; Bellinvia S Dig Liver Dis; 2005 Feb; 37(2):135-6. PubMed ID: 15733528 [No Abstract] [Full Text] [Related]
34. A single center experience of methotrexate in the treatment of Crohn's disease and ulcerative colitis: a case for subcutaneous administration. Nathan DM; Iser JH; Gibson PR J Gastroenterol Hepatol; 2008 Jun; 23(6):954-8. PubMed ID: 17559377 [TBL] [Abstract][Full Text] [Related]
36. Anastomotic configuration and mucosal 5-aminosalicyclic acid (5-ASA) concentrations in patients with Crohn's disease: a GISC study. Gruppo Italiano per lo Studio del Colon e del Retto. Frieri G; Pimpo MT; Palumbo G; Tonelli F; Annese V; Sturniolo GC; Andreoli A; Comberlato M; Corrao G; Caprilli R Am J Gastroenterol; 2000 Jun; 95(6):1486-90. PubMed ID: 10894584 [TBL] [Abstract][Full Text] [Related]
37. Aminosalicylates for active disease and in the maintenance of remission in Crohn's disease. Feagan BG Eur J Surg; 1998 Dec; 164(12):903-9. PubMed ID: 10029385 [No Abstract] [Full Text] [Related]
38. [The conservative treatment of nonspecific inflammatory bowel diseases]. Wojtuń S; Gil J; Chojnacki J; Wichan P Pol Merkur Lekarski; 2004; 17 Suppl 1():35-9. PubMed ID: 15603344 [TBL] [Abstract][Full Text] [Related]
39. Development of Crohn's disease in a patient taking etanercept. Oh J; Arkfeld DG; Horwitz DA J Rheumatol; 2005 Apr; 32(4):752-3. PubMed ID: 15801037 [TBL] [Abstract][Full Text] [Related]